Medical Facilities (TSE:DR) Sets New 12-Month High - Still a Buy?

Medical Facilities Co. (TSE:DR - Get Free Report) hit a new 52-week high on Friday . The stock traded as high as C$16.87 and last traded at C$16.50, with a volume of 176817 shares traded. The stock had previously closed at C$15.50.

Wall Street Analyst Weigh In

Separately, Leede Financial downgraded shares of Medical Facilities from a "strong-buy" rating to a "hold" rating in a report on Thursday, November 7th.

Medical Facilities Stock Performance

The company has a debt-to-equity ratio of 86.99, a current ratio of 1.15 and a quick ratio of 1.51. The stock has a fifty day moving average price of C$15.62 and a two-hundred day moving average price of C$14.39. The company has a market cap of C$401.64 million, a P/E ratio of 15.18, a PEG ratio of 3.81 and a beta of 0.47.

Insider Activity at Medical Facilities

In other news, Director Yanick Blanchard sold 100,000 shares of the company's stock in a transaction on Friday, November 15th. The stock was sold at an average price of C$15.93, for a total value of C$1,593,100.00. Also, Senior Officer David Nathaniel Tait Watson sold 7,800 shares of Medical Facilities stock in a transaction dated Wednesday, December 18th. The stock was sold at an average price of C$16.31, for a total value of C$127,218.00. Following the transaction, the insider now directly owns 100 shares in the company, valued at approximately C$1,631. The trade was a 98.73 % decrease in their ownership of the stock. Company insiders own 0.43% of the company's stock.

Medical Facilities Company Profile

Medical Facilities Corp owns a diverse portfolio of surgical facilities in the United States. Through its wholly-owned subsidiaries, the company owns controlling interests in four specialty hospitals and six ambulatory surgery centers. The hospitals offer a range of non-emergency surgical, imaging, diagnostic and pain management procedures, and other ancillary services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.